Morning Overview on MSN
An SGLT2 pill protected the kidneys of teenagers with type 1 diabetes in a new trial
Teenagers with type 1 diabetes now have the first randomized trial evidence that an SGLT2 inhibitor can protect their kidneys ...
Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhea, according to the results of the world's largest ...
Conversation Continues: Addressing the Persistent Gap in Female Sexual Health for Cancer Survivors We demonstrate a model collaboration between investigators and a state cannabis program to overcome ...
Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...
Uncontrolled hypertension disproportionately affects populations that have substantial health disparities. Data regarding the effectiveness and implementation of multifaceted, team-based strategies ...
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP The pathobiology of chronic ...
Researchers found similar HPV infection and clearance rates among women using injectable contraception, copper IUDs, and ...
Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhea, according to the results of the world's largest ...
The US Food and Drug Administration (FDA) this week published a draft guidance on the use of master protocols in clinical trials of drugs and biologics research that replaces a pandemic-era guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results